Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 76

1.

Distinct iron architecture in SF3B1-mutant myelodysplastic syndrome patients is linked to an SLC25A37 splice variant with a retained intron.

Visconte V, Avishai N, Mahfouz R, Tabarroki A, Cowen J, Sharghi-Moshtaghin R, Hitomi M, Rogers HJ, Hasrouni E, Phillips J, Sekeres MA, Heuer AH, Saunthararajah Y, Barnard J, Tiu RV.

Leukemia. 2014 May 23. doi: 10.1038/leu.2014.170. [Epub ahead of print]

PMID:
24854990
[PubMed - as supplied by publisher]
2.

Cancer stem cell-specific scavenger receptor 36 drives glioblastoma progression.

Hale JS, Otvos B, Sinyuk M, Alvarado AG, Hitomi M, Stoltz K, Wu Q, Flavahan W, Levison B, Johansen ML, Schmitt D, Neltner JM, Huang P, Ren B, Sloan AE, Silverstein RL, Gladson CL, DiDonato JA, Brown JM, McIntyre T, Hazen SL, Horbinski C, Rich JN, Lathia JD.

Stem Cells. 2014 Jul;32(7):1746-58. doi: 10.1002/stem.1716.

PMID:
24737733
[PubMed - in process]
3.

High-throughput flow cytometry screening reveals a role for junctional adhesion molecule a as a cancer stem cell maintenance factor.

Lathia JD, Li M, Sinyuk M, Alvarado AG, Flavahan WA, Stoltz K, Rosager AM, Hale J, Hitomi M, Gallagher J, Wu Q, Martin J, Vidal JG, Nakano I, Dahlrot RH, Hansen S, McLendon RE, Sloan AE, Bao S, Hjelmeland AB, Carson CT, Naik UP, Kristensen B, Rich JN.

Cell Rep. 2014 Jan 16;6(1):117-29. doi: 10.1016/j.celrep.2013.11.043. Epub 2013 Dec 27.

PMID:
24373972
[PubMed - in process]
Free Article
4.

Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A.

Lotti F, Jarrar AM, Pai RK, Hitomi M, Lathia J, Mace A, Gantt GA Jr, Sukhdeo K, DeVecchio J, Vasanji A, Leahy P, Hjelmeland AB, Kalady MF, Rich JN.

J Exp Med. 2013 Dec 16;210(13):2851-72. doi: 10.1084/jem.20131195. Epub 2013 Dec 9.

PMID:
24323355
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake.

Flavahan WA, Wu Q, Hitomi M, Rahim N, Kim Y, Sloan AE, Weil RJ, Nakano I, Sarkaria JN, Stringer BW, Day BW, Li M, Lathia JD, Rich JN, Hjelmeland AB.

Nat Neurosci. 2013 Oct;16(10):1373-82. doi: 10.1038/nn.3510. Epub 2013 Sep 1.

PMID:
23995067
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Aptamer identification of brain tumor-initiating cells.

Kim Y, Wu Q, Hamerlik P, Hitomi M, Sloan AE, Barnett GH, Weil RJ, Leahy P, Hjelmeland AB, Rich JN.

Cancer Res. 2013 Aug 1;73(15):4923-36. doi: 10.1158/0008-5472.CAN-12-4556. Epub 2013 Jun 24.

PMID:
23796560
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Myo1c facilitates G-actin transport to the leading edge of migrating endothelial cells.

Fan Y, Eswarappa SM, Hitomi M, Fox PL.

J Cell Biol. 2012 Jul 9;198(1):47-55. doi: 10.1083/jcb.201111088.

PMID:
22778278
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Platelet-derived growth factor receptors differentially inform intertumoral and intratumoral heterogeneity.

Kim Y, Kim E, Wu Q, Guryanova O, Hitomi M, Lathia JD, Serwanski D, Sloan AE, Weil RJ, Lee J, Nishiyama A, Bao S, Hjelmeland AB, Rich JN.

Genes Dev. 2012 Jun 1;26(11):1247-62. doi: 10.1101/gad.193565.112.

PMID:
22661233
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions.

Lathia JD, Hitomi M, Gallagher J, Gadani SP, Adkins J, Vasanji A, Liu L, Eyler CE, Heddleston JM, Wu Q, Minhas S, Soeda A, Hoeppner DJ, Ravin R, McKay RD, McLendon RE, Corbeil D, Chenn A, Hjelmeland AB, Park DM, Rich JN.

Cell Death Dis. 2011 Sep 1;2:e200. doi: 10.1038/cddis.2011.80.

PMID:
21881602
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Glioma stem cell maintenance: the role of the microenvironment.

Heddleston JM, Hitomi M, Venere M, Flavahan WA, Yang K, Kim Y, Minhas S, Rich JN, Hjelmeland AB.

Curr Pharm Des. 2011;17(23):2386-401. Review.

PMID:
21827414
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

The checkpoint kinase ATM protects against stress-induced elevation of cyclin D1 and potential cell death in neurons.

Hitomi M, Stacey DW.

Cytometry A. 2010 Jun;77(6):524-33. doi: 10.1002/cyto.a.20885.

PMID:
20506465
[PubMed - indexed for MEDLINE]
Free Article
12.

Development of high-speed polarizing imaging system for operation in high pulsed magnetic field.

Katakura I, Tokunaga M, Matsuo A, Kawaguchi K, Kindo K, Hitomi M, Akahoshi D, Kuwahara H.

Rev Sci Instrum. 2010 Apr;81(4):043701. doi: 10.1063/1.3359954.

PMID:
20441339
[PubMed]
13.

Phosphorylation of cyclin D1 regulated by ATM or ATR controls cell cycle progression.

Hitomi M, Yang K, Stacey AW, Stacey DW.

Mol Cell Biol. 2008 Sep;28(17):5478-93. doi: 10.1128/MCB.02047-07. Epub 2008 Jul 7.

PMID:
18606783
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Cell cycle studies based upon quantitative image analysis.

Stacey DW, Hitomi M.

Cytometry A. 2008 Apr;73(4):270-8. doi: 10.1002/cyto.a.20511. Review.

PMID:
18163464
[PubMed - indexed for MEDLINE]
Free Article
15.
16.

p27Kip1 and cyclin dependent kinase 2 regulate passage through the restriction point.

Hitomi M, Yang K, Guo Y, Fretthold J, Harwalkar J, Stacey DW.

Cell Cycle. 2006 Oct;5(19):2281-9. Epub 2006 Oct 1.

PMID:
16969133
[PubMed - indexed for MEDLINE]
Free Article
17.

Glycogen synthase kinase 3 has a limited role in cell cycle regulation of cyclin D1 levels.

Yang K, Guo Y, Stacey WC, Harwalkar J, Fretthold J, Hitomi M, Stacey DW.

BMC Cell Biol. 2006 Aug 30;7:33.

PMID:
16942622
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Vitamins K2, K3 and K5 exert in vivo antitumor effects on hepatocellular carcinoma by regulating the expression of G1 phase-related cell cycle molecules.

Kuriyama S, Hitomi M, Yoshiji H, Nonomura T, Tsujimoto T, Mitoro A, Akahane T, Ogawa M, Nakai S, Deguchi A, Masaki T, Uchida N.

Int J Oncol. 2005 Aug;27(2):505-11.

PMID:
16010434
[PubMed - indexed for MEDLINE]
19.

In vitro and in vivo antitumor effects of vitamin K5 on hepatocellular carcinoma.

Hitomi M, Nonomura T, Yokoyama F, Yoshiji H, Ogawa M, Nakai S, Deguchi A, Masaki T, Inoue H, Kimura Y, Kurokohchi K, Uchida N, Kuriyama S.

Int J Oncol. 2005 May;26(5):1337-44.

PMID:
15809726
[PubMed - indexed for MEDLINE]
20.

Phosphorylation of cyclin D1 at Thr 286 during S phase leads to its proteasomal degradation and allows efficient DNA synthesis.

Guo Y, Yang K, Harwalkar J, Nye JM, Mason DR, Garrett MD, Hitomi M, Stacey DW.

Oncogene. 2005 Apr 14;24(16):2599-612.

PMID:
15735756
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk